Zogenix, Inc.
Industry
- Biotechnology
- Pharmaceuticals
Other Names/Subsidiaries
- Brabant Pharma, Modis Therapeutics, Inc. Zogenix International, Ltd. Zogenix Europe Limited
Latest on Zogenix, Inc.
UCB has become the latest Europe drugmaker to pledge major manufacturing investments in the US amid the pressure being put on the pharmaceutical sector by President Trump administration to move more d
AstraZeneca PLC ’s Imfinzi became the second cancer immunotherapy approved for perioperative use in resectable non-small cell lung cancer (NSCLC) on 15 August, despite the US Food and Drug Administrat
UCB S.A. won US Food and Drug Administration approval for two key products needed to help the company return to growth – Bimzelx (bimekizumab-bkzx) for adults with moderate-to-severe plaque psoriasis
As it waits patiently for US approval for Bimzelx in psoriasis, UCB S.A. has given an insight into the European launch of the potential autoimmune disease blockbuster which has started fairly slowly